quinazolines has been researched along with Nocturia in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Akarasakul, D; Choeypunt, N; Chotikawanich, E; Kongwiwatanakul, S; Leungwattanakij, S; Lojanapiwat, B; Noppakulsatit, P; Permpongkosol, S; Petchpaibuol, T; Pripatnanont, C; Tantiwong, A; Tongbai, T; Wanamkang, T; Watanachote, D | 1 |
| Alcaraz, A; Elhilali, M; Emberton, M; Hartung, R; Harving, N; Matzkin, H; Vallancien, G; van Moorselaar, RJ | 1 |
1 trial(s) available for quinazolines and Nocturia
| Article | Year |
|---|---|
Sexuality and management of benign prostatic hyperplasia with alfuzosin: SAMBA Thailand.
Topics: Adrenergic alpha-1 Receptor Antagonists; Aged; Ejaculation; Erectile Dysfunction; Humans; Male; Middle Aged; Nocturia; Prostatic Hyperplasia; Quinazolines; Severity of Illness Index; Thailand | 2010 |
1 other study(ies) available for quinazolines and Nocturia
| Article | Year |
|---|---|
Alfuzosin 10 mg once daily for treating benign prostatic hyperplasia: a 3-year experience in real-life practice.
Topics: Adrenergic alpha-Antagonists; Aged; Disease Progression; Erectile Dysfunction; Humans; Male; Nocturia; Patient Satisfaction; Prostatic Hyperplasia; Prostatism; Quality of Life; Quinazolines; Sexual Dysfunction, Physiological; Treatment Outcome; Urinary Retention | 2008 |